Drugmakers' Oil-For-Food Dealings Investigated

December 2007 | Company News Alert

Three leading pharmaceutical companies have become the focus of investigations into allegations of corruption involving UK firms that exported goods to Iraq through the UN's oil-for-food programme. Several UK infrastructure companies including bridge-builders Mabey and Johnson have been subject to investigation by the UK's Serious Fraud Office (SFO) since it launched its own inquiry in March 2007 to supplement an inquiry by the US Securities and Exchange Commission (SEC). However, the probe has been widened to include UK-based GlaxoSmithKline, Anglo-Swedish drugmaker AstraZeneca and the UK arm of US-based Eli Lilly. All three have been asked to hand files detailing their

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.